PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A systematic review and meta-analysis of eight RCTs evaluated its efficacy and safety for cancer-related fatigue and quality of life [PMID:40302232]
A systematic review and meta-analysis of 66 studies involving 4785 participants suggested potential benefits as an adjunctive therapy [PMID:31034954]
A Cochrane systematic review assessed the effectiveness and safety of oral Astragalus for preventing frequent episodes [PMID:27905672]
Demonstrated anti-tumor effects, immune regulation, and prevention of postoperative recurrence and metastasis [PMID:36587879]
Preclinical evidence suggests it may improve intestinal barrier integrity and suppress pro-inflammatory cytokines [PMID:40817502, PMID:37530507]
Safety & adverse effects
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 35713852 (2022) — Astragalus polysaccharide: a review of its immunomodulatory effect. · Archives of pharmacal research
- 2.PMID: 26916911 (2016) — Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers. · The American journal of Chinese medicine
- 3.PMID: 39215362 (2024) — Astragali radix (Huangqi): a time-honored nourishing herbal medicine. · Chinese medicine
- 4.PMID: 37054858 (2023) — Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus. · International journal of biological macromolecules
- 5.PMID: 25087616 (2014) — Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi).